Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kazi A. Aftab"'
Autor:
Mohammad Saifuddin, Ajit K. Paul, Sultana M. Shefin, Md. Jahangir Alam, Shahjada Selim, Sunjida Islam, Tanjina Hossain, Sadiqa Tuqan, Nusrat Sultana, Marufa Mustari, Ramen C. Basak, Kazi A. Aftab, Indrajit Prasad, Mohammad R. Uddin, Shoma Sharker, Md. Abu Jar Gaffar, Mohammad M. Rahman, Mohammad A. Hannan, Afsar Ahammed, ABM Kamrul-Hasan
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 28, Iss 5, Pp 500-509 (2024)
Background: Empagliflozin is a relatively newer glucose-lowering drug (GLD) with many extra-glycemic benefits. To date, no study has evaluated the efficacy and safety of empagliflozin in Bangladeshi patients with type 2 diabetes mellitus (T2DM). Obje
Externí odkaz:
https://doaj.org/article/70e8fbdd22054143beaad373bede1e9c
Autor:
Mohammad Mahfuzul Hoque, Ponkaj Kanti Datta, Kamalesh Chandra Basu, Muhammad Faizur Rahman, Mohammed Masudul Hassan Khan, Mohammad Mostafa Kamal, Reaz Mahmud, Kazi Ali Aftab, Ejrarul Alam Khan, Imran Mahmud, Rumana Sharmin, Md Abdullah Saeed Khan, Mohammad Jahid Hasan, Md Robed Amin, Md Titu Miah, Md Mujibur Rahman
Publikováno v:
PLoS ONE, Vol 18, Iss 1, p e0280882 (2023)
There is increasing evidence of the post-COVID-19 suffering and decreased quality of life in the COVID-19 patients. This study aimed to assess the quality of life and associated factors of COVID-19 patients at one month after discharge from the hospi
Externí odkaz:
https://doaj.org/article/d046254aa3db4440bec0a4609ab9a758